Patients often report: Reduction in bloating and abdominal pain within 2-3 weeks Improved bowel movement regularity by week 4-6 Enhanced tolerance to previously problematic foods by week 8-12 Reduced systemic inflammation (measured by CRP, ESR) after 12 weeks of consistent use BPC-157 for Musculoskeletal Healing: Tendons, Ligaments, and Joints For musculoskeletal applications, BPC-157 is typically administered via subcutaneous injection near the injury site
(September 2008)
Sikiric, P., Seiwerth, S., Grabarevic, Z., et al
By providing a meticulously synthesized, 99% pure peptide in flexible sizesfrom 5mg pilot vials to 15mg extended-study vialsit delivers the consistency researchers need to study wound healing and angiogenesis at any scale
Peptides that should NOT use bacteriostatic water Not all peptides are compatible with bacteriostatic water
Proton-pump inhibitors (e.g., omeprazole, esomeprazole, and lansoprazole), used to treat Zollinger-Ellison syndrome and gastroesophageal reflux disease (GERD), markedly decrease stomach acid secretion required for the release of vitamin B 12 from food but not from supplements
